Pathogenesis of cardiomyopathy caused by anthracycline antibiotics: Effect of pulmonary stenosis on the development of cardiomyopathy

Cardiovascular Pathology

Volumn 7, Issue 4, 1998, Pages 215-222

  Minamide, Seiki ^a   Kanezawa, Norio ^a   Suzuki, Tadashi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNORUBICIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; MALE; MECHANICAL STRESS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTO ONCOGENE; PULMONARY ARTERY STENOSIS;

EID: 0031825274     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(97)00112-9     Document Type: Article

References (26)

1. 10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity. Biochem Biophys Res Commun. 58:1974;633-638.
2. Bonadonna G., Monfardini S. Cardiac toxicity of daunorubicin. Lancet. 1:1969;837.
3. Blum R.H., Carter S.K., Adriamycin A new anticancer drug with significant clinical activity. Ann Intern Med. 80:1974;249-259.
4. Buja L.M., Ferrans V.J., Mayer R.J., Roberts W.C., Henderson E.S. Cardiac ultrastructural changes induced by daunomycin therapy. Cancer. 32:1973;771-788.
5. Bristow M.R., Mason J.W., Billingham M.E., Daniel J.R. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J. 102:1981;709-718.
6. Suzuki T., Kanda H., Kawai Y., Tominaga K., Murata K. Cardiotoxicity of anthracycline antineoplastic drugs - Clinicopathological and experimental studies. Jpn Circ J. 43:1979;1000-1008.
7. Jaenke R.S. An anthracycline antibiotic-induced cardiomyopathy in rabbits. Lab Invest. 30:1974;292-304.
8. Ferrans V.J. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat Rep. 62:1978;955-960.
9. Von Hoff D.D., Layard M.W., Basa P.et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 91:1979;710-717.
10. Yamamoto H. Ultrastructural changes in myocardium induced by a single dose of doxorubicin in rabbits. J Clin Electron Microscopy. 19:1986;127-142.
11. Iwasaki T., Suzuki T. Ultrastructural changes in myocardium induced by doxorubicin - A study by ultramicrotomy and freeze-fracture method. J Clin Electron Microscopy. 23:1990;121-134.
12. Kishi T., Watanabe T., Folkers K. Bioenergetics in clinical medicine. prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium Proc Natl Acad Sci USA. 73:1976;4653-4656.
13. Olson H.M., Young D.M., Prieur D.J., LeRoy A.F., Reagan R.L. Electroyte and morphologic alteration of myocardium in adriamycin-treated rabbits. Am J Pathol. 7:1974;439-454.
14. Myers C., McGuire W.P., Liss R.H., Ifrim I., Grozinger K., Joung R.C. Adriamycin. The role of lipid peroxidation in cardiactoxicity and tumor response Science. 197:1977;165-167.
15. Doroshow J.H. Effects of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Research. 43:1983;460-472.
16. Minow R.A., Benjamin R.S., Gottlieb J.A. Adrianycin (Nsc-123127) cardiomyopathy - An overview with determination of risk factors. Cancer Chemother Rep. 6:1975;195-201.
17. Suzuki T., Minamide S., Iwasaki T., Yamamoto H., Kanda H. Cardiotoxicity of a new anthracycline derivative (Sm-5887) following intravenous administration to rabbits. Comparative study with doxorubicin Investigational New Drugs. 15:1997;219-225.
18. Van Vleet J.F., Ferrans V.J., Weirich W.E. Cardiac disease induced by chronic adriamycin administration in dogs and evaluation of vitamin E and selenium as cardioprotectants. Am J Pathol. 99:1980;13-42.
19. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
20. Laks M.M., Morady F., Garner D., Swan H.J. Relation of ventricular volume, compliance, and mass in the normal and pulmonary arterial banded canine heart. Cardiovasc Res. 6:1972;187-198.
21. Morady F., Laks M.M., Parmeley W.W. Comparison of sarcomere lengths from normal and hypertrophied inner and middle canine right ventricle. Am J Pathol. 225:1973;1257-1259.
22. Komuro I., Kaida T., Shibazaki Y.et al. Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem. 265:1990;3595-3598.
23. Schreiber S.S., Oratz M., Rothschild M.A. Effect of acute overload on protein synthesis in cardiac muscle microsomes. Am J Physiol. 213:1967;1552-1555.
24. Zak R., Martin A.F., Reddy M.K., Rabinowitz M. Control of protein balance in hypertrophied cardiac muscle. Circ Res. 38:1976;1145-1150.
25. Zak R. Metabolism of myofibrillar proteins in the normal and hypertrophic heart. Basic Res Cardiol. 72:1977;235-240.
26. Laurent G.J., Sparraow M.P., Millward D.J. Turnover of muscle protein in the fowl. Changes in rates of protein synthesis and breakdown during hypertrophy of the anterior and posterior latissimus dorsi muscles. Biochem J. 176:1978;407-417.